Ifp Advisors, Inc Avrobio, Inc. Transaction History

Ifp Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 12, 2023	BUY	$0.98 - $1.62 $3,430 - $5,670	3,500 New	3,500 $5,000
Q3 2021 Oct 06, 2021	SELL	$5.53 - $9.28 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$7.84 - $12.6 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$10.54 - $19.3 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$12.79 - $17.1 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$12.99 - $19.41 $0 - $0	0 New	0 $0

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.